Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4279083017 | Maftivimab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4279084011 | Maftivimab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4801051000052117 | maftivimab | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Maftivimab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Maftivimab | Is a | Substance with antiviral mechanism of action (substance) | true | Inferred relationship | Some | ||
| Maftivimab | Has disposition (attribute) | Antiviral (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing atoltivimab and maftivimab and odesivimab (medicinal product) | Has active ingredient | True | Maftivimab | Inferred relationship | Some | 2 |
| Product containing only atoltivimab and maftivimab and odesivimab (medicinal product) | Has active ingredient | True | Maftivimab | Inferred relationship | Some | 2 |
| Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form | Has active ingredient | True | Maftivimab | Inferred relationship | Some | 2 |
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Has active ingredient | True | Maftivimab | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR